Variation in Medicaid and commercial coverage of cell and gene therapies

• Κύριοι συγγραφείς: Molly T. Beinfeld (Συγγραφέας), Julia A. Rucker (Συγγραφέας), Nola B. Jenkins (Συγγραφέας), Lucas A. de Breed (Συγγραφέας), James D. Chambers (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2023-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Growth in the availability of cell and gene therapies (CGTs) promises significant innovation in the treatment of serious diseases, but the high cost and one-time administration of CGTs has also raised concern about strain on health plan budgets and inequity in access. We used coverage information fr...